The UEF Cancer AI team launched a challenge for estimating breast density from mammograms. Addressing limitations in existing tools, the challenge seeks innovative deep-learning architectures. Participants work with a dataset of 569 mammogram images,…
Continue Reading
What You Should Know:
– Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer.
– This…
Continue Reading
Hologic’s RSNA 2023 unveiling presented Genius AI Detection 2.0, a groundbreaking technology slashing false-positive markings by 70%. Alongside SecurView 12.0, it streamlines lesion correlation for expedited reviews. Erik Anderson emphasized their commitment to enhancing…
Continue Reading
ScreenPoint Medical’s Transpara AI has analyzed 5 million mammograms and 1 million Tomosynthesis studies, spotlighting at RSNA 2023. Studies reveal its role as a ‘second pair’ of eyes aiding cancer detection, and reducing recall…
Continue Reading
iCAD and CancerIQ have united to create an advanced breast healthcare solution. Their partnership merges iCAD’s AI-driven ProFound Breast Health Suite with CancerIQ’s precision platform, enhancing breast cancer risk prediction and personalized care plans….
Continue Reading
AI’s impact on healthcare unfolds through HEALWELL AI’s acquisition of Pentavere, fortifying data-driven diagnostics. Forward Health introduces CarePods, reshaping accessibility to comprehensive medical services. Lunit’s FDA clearance for breast cancer detection highlights AI’s pivotal…
Continue Reading
What You Should Know:
SciBase Holding AB, a developer of augmented intelligence-based solutions for skin disorders, has entered into a collaboration agreement with the Skin and Cancer Institute to pilot Nevisense in several of their…
Continue Reading
The RSNA Margulis Award-winning study introduces a game-changing AI-driven tool for pancreatic cancer detection on CT scans. Led by Po-Ting Chen, M.D., and the team, the research showcases the tool’s 90% sensitivity and 93%…
Continue Reading
Dr. Robert Bard, a leader in radiological diagnostics, advocates for 3D Doppler imaging’s role in non-invasive cancer detection, particularly in breast, prostate, and skin cancers. Highlighting its precision and the reduced need for biopsies,…
Continue Reading
Paige, a global leader in digital pathology solutions, has received the FDA’s Breakthrough Device Designation for Paige Lymph Node. This AI application is a pioneering tool for detecting breast cancer metastases in lymph nodes….
Continue Reading
